Antipsychotic drugs: problems and guidelines
Wengert, J.W.; Ahmed, I.
Nebraska Medical Journal 64(5): 139-140
1979
ISSN/ISBN: 0091-6730 PMID: 35759 Document Number: 140249
Document emailed within 1 workday
Related Documents
Wyller, T.B.; Engebråten, O. 1998: Use of antipsychotic drugs in a long-term care institution. Experiences with implementing clinical guidelines Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(14): 2144-2147Vieta, E. 2004: Antipsychotic drugs and pregnancy Medicina clinica 123(13): 517-8; author reply 518
Bourin, M. 2006: Pharmacology of antipsychotic drugs L'Encephale 32 Pt 2: S8-S9
Vanden Bussche, G.; Gelders, Y.G.; Heylen, S.L. 1990: Development of new antipsychotic drugs Acta Psiquiatrica y Psicologica de America Latina 36(1-2): 13-25
Raskind, M.A.; Risse, S.C. 1986: Antipsychotic drugs and the elderly Journal of Clinical Psychiatry 47 Suppl: 17-22
Loga, S.; Loga-Zec, S. 2010: Psychiatrists between personal freedom to prefer antipsychotic in treatment of schizophrenic patients and algorithms and guidelines Psychiatria Danubina 22(2): 343-345
Rimón, R.; Leinonen, E. 2002: Should the second generation antipsychotic agents be used as drugs of choice? Duodecim; Laaketieteellinen Aikakauskirja 118(6): 585-590
Deuschle, M. 2005: Diabetes in treatment with antipsychotic drugs: who is at risk] MMW Fortschritte der Medizin 147(51-52): 34
Lee, B.S. 1986: Possibility of hyperpyrexia with antipsychotic and anticholinergic drugs Journal of Clinical Psychiatry 47(11): 571
Dumortier, G.; Cabaret, W.; Stamatiadis, L.; Saba, G.; Benadhira, R.; Rocamora, J.-F.; Aubriot-Delmas, B.; Glikman, J.; Januel, D. 2002: Hepatic tolerance of atypical antipsychotic drugs L'Encephale 28(6 Part 1): 542-551
Laux, G. 2003: Pharmaco-economic aspects of antidepressants and antipsychotic drugs Psychiatrische Praxis 30(Suppl 2): S90-S93
Tokunaga, H.; Kudo, K.; Imamura, T.; Jitsufuchi, N.; Ohtsuka, Y.; Ikeda, N. 1997: Plasma concentrations of antipsychotic drugs in psychiatric inpatients Nihon Hoigaku Zasshi 51(6): 417-422
Baptista, T. 2002: Mechanisms of weight gain induced by antipsychotic drugs Journal of Clinical Psychiatry 63(3): 245-246
Cavanaugh, J.J.; Finlayson, R.E. 1984: Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs Journal of Clinical Psychiatry 45(8): 356-357
Hashimoto, K.; Iyo, M. 2002: Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs Nihon Shinkei Seishin Yakurigaku Zasshi 22(1): 3-13
Firestone, A. 2005: Weight gain and diabetes with "second-generation" antipsychotic drugs Medical Journal of Australia 182(12): 652-653
Gaebel, W. 1997: Towards the improvement of compliance: the significance of psycho-education and new antipsychotic drugs International Clinical Psychopharmacology 12(Suppl): S37-S42
Weiden, P.; Aquila, R.; Standard, J. 1996: Atypical antipsychotic drugs and long-term outcome in schizophrenia Journal of Clinical Psychiatry 57(Suppl): 53-60
Lambert, M.; Naber, D.; Perro, C.; Moritz, S.; Krausz, M. 1999: Success of new treatments for schizophrenics, as shown by the example of modern antipsychotic drugs Psychiatrische Praxis 26(Suppl 1): S30-S35
Vuk, A.; Kuzman, M.Rojnic.; Baretic, M.; Osvatic, M.Matovinovic. 2017: Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature Psychiatria Danubina 29(2): 121-135